Shexiang Baoxin Pill for Heart Attack Treatment
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a traditional Chinese medicine pill (Shexiang Baoxin) can help people having a heart attack. It is given along with standard care, including a procedure to open blocked heart arteries (PCI).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a heart attack with chest pain lasting 20 minutes or more.
- You have ECG changes or high troponin levels confirming the heart attack.
- You start treatment within 24 hours of symptoms and are scheduled for a PCI procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial tests whether combining antioxidant supplements with standard heart attack care can reduce heart muscle damage. It may help people who are getting emergency treatment for their first heart attack.
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
This Phase 4 trial studies whether Suxiao Jiuxin Pill can stabilize “vulnerable” plaque in people after an acute heart attack. It may help reduce risky heart-related complications when doctors are planning emergency coronary angiography and stent/PCI treatment.
This trial tests whether Guanxinning Tablet, a Chinese herbal medicine, can improve blood flow in the tiny vessels of the heart after an acute heart attack (STEMI) treated with emergency angioplasty. The study measures heart function changes over 6 months using imaging.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.